Physician
Valley Arthritis Care LLC
Valley Arthritis Care LLC was paid $1.78M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.
33Billing provider infoVALLEY ARTHRITIS CARE LLC
PEORIA, AZ 85381
PEORIA, AZ 85381
33aNPI1114965779assigned 06/03/2006
33bProvider typeRheumatology Physician
28Total paid$1.78M
24GClaims42,567
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in Arizona
Rank by total paid#1 of 23
Median peer was paid$58K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,985 | $456K | |
| 2019 | 7,148 | $200K | |
| 2020 | 4,209 | $127K | |
| 2021 | 4,951 | $289K | |
| 2022 | 5,439 | $213K | |
| 2023 | 5,705 | $250K | |
| 2024incomplete | 5,130 | $245K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 12,961 | 12,529 | $704K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 7,304 | 6,944 | $268K |
| J0897 | Injection, denosumab, 1 mg | 9.6% | 355 | 348 | $171K |
| J0490 | Injection, belimumab, 10 mg | 6.7% | 148 | 92 | $120K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5.6% | 1,196 | 1,105 | $99K |
| J3262 | Injection, tocilizumab, 1 mg | 5.6% | 131 | 67 | $99K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.6% | 6,882 | 6,268 | $64K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 696 | 690 | $64K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2.9% | 41 | 38 | $52K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 853 | 772 | $32K |
| 20553 | 1.5% | 827 | 810 | $28K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 2,524 | 2,285 | $24K |
13 more codes
| 99442 | <1% | 407 | $16K | |
| 96415 | <1% | 577 | $16K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 38 | $5K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 624 | $4K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,014 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,186 | $3K |
| 20611 | <1% | 40 | $3K | |
| 77080 | <1% | 149 | $2K | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 390 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,315 | $1K |
| 20610 | <1% | 20 | $677.37 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 809 | $263.76 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 80 | $61.53 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBHALLA, RAVI (PRESIDENT)